Hint mode is switched on Switch off
For swift navigation between sections

Sanofi
LEI 549300E9PC51EN656011, SWIFT SAAVFRPPXXX

PDF download

Choose all Reset all
Download Cancel
Organization name
Sanofi SA
Country name
France
Country of registration
France
Industry
Pharmaceutical Preparation and Biotechnology
Bond debt
17,844 mln USD

explore the most comprehensive database

900 000

bonds globally

Over 400

pricing sources

80 000

stocks

116 000

ETF & Funds

track your portfolio in the most efficient way

  • Bond Search
  • Watchlist
  • Excel ADD-IN
Get access
×

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 900 000 bonds, 80 000 stocks, 116 000 ETF & Funds; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Register
×

Why

You will have detailed descriptive & pricing data for 650K bonds, 76K stocks, 8K ETFs
Get full access to the platform from any device & via Cbonds app
Enhance your portfolio management with Cbonds Excel Add-in
Build yield maps, make chart comparison within a click
Don't wait any longer — start using Cbonds today! Register

Latest data on

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

Sanofi SA, formerly Sanofi-Aventis, is a global and diversified healthcare company. The Company discovers, develops and distributes therapeutic solutions focused on patients needs. Sanofi focuses on the field of healthcare with six growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets and animal health. Sanofi has a portfolio of prescription drugs, vaccines, generics and consumer healthcare products. In December 2011, Sanofi announced that it completed the divestiture of its dermatology business, Dermik, to Valeant Pharmaceuticals International, Inc. The Company is active domestically and abroad, including other European countries, North and Latin Americas, Asia, Africa and Middle East. As of January 31, 2012, the Companys major shareholder was Loreal with a stake of 8.82%.

Awards

News

27/05/2025 Sanofi and VNVC Open Vaccine Manufacturing Hub in Vietnam
07/05/2025 Moody's Investors Service upgrades LT- local currency credit rating of Sanofi to "Aa3" from "A1"; outlook stable
07/05/2025 Moody's Investors Service upgrades LT- foreign currency credit rating of Sanofi to "Aa3" from "A1"; outlook stable
07/05/2025 Moody's Ratings upgrades Sanofi to Aa3; outlook stable (Rating action commentary)
28/04/2025 S&P Global Ratings affirms Sanofi at "AA" (Foreign Currency LT credit rating); outlook stable
All organization news

Documentation

IFRS/US GAAP reports

2024
II q eng
IV q eng
2023
II q eng
IV q eng
2022
II q eng
IV q eng
2021
II q eng
IV q eng
2020
II q eng
IV q eng
2019
II q eng
IV q eng
2018
II q eng
IV q eng
2017
IV q eng
Show all Hide
Authorization required
You need to request access

Stocks

Latest issues

Show all

Public debt by currencies

Show more Hide

Codes

  • LEI
    549300E9PC51EN656011
  • SWIFT
    SAAVFRPPXXX
  • SIC
    2834 PHARMACEUTICAL PREPARATIONS
  • ICB
    4,500 Health Care
  • CIK
    0001121404
  • EIN
    13-3529324
  • SIREN
    395030844
Registration is required to get access.